Legend Biotech Corporation American Depositary Shares

LEGN

...

LEGN: Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy is for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America.

Show LEGN Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of LEGN by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by LEGN's directors and management

No recent Insider Trading for this ticker

Insider Trading Dashboard

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on LEGN's company Twitter account

WallStreetBets

Number of mentions of LEGN in WallStreetBets Daily Discussion

LEGN News

Recent insights relating to LEGN

CNBC Recommendations

Recent picks made for LEGN stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in LEGN

Corporate Flights

Flights by private jets registered to LEGN